User:Mr. Ibrahem/Edoxaban

Edoxaban, sold under the brand-name Lixiana among others, is a anticoagulant (blood thinner) used to prevent and treat blood clots. It is not clear if it is safe with prosthetic heart valves. It is taken by mouth once a day; either 30mg or 60mg depending on body weight and kidney function.

Common side effects include nose bleeds, blood in the urine, and anemia. Other side effects may include nausea, skin rash, and brain bleeding. Compared with warfarin it has fewer interactions. It is in the direct factor Xa inhibitors family of medications.

Edoxaban was developed by Daiichi Sankyo and approved for medical use in Japan in 2011. Approval in the United States and Europe occurred in 2015. It is on the World Health Organization's List of Essential Medicines as an alternative to dabigatran. In the UK, a month supply costs the NHS around £50 as of 2021, more than 50 times that of warfarin, although this difference may be offset by lower monitoring costs. This amount in the United States costs about 390USD.